73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Minimal residual disease negativity predicts time to next treatment in multiple myeloma

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN
Potential way to treat and prevent cancer in children with neuroblastoma

Potential way to treat and prevent cancer in children with neuroblastoma

by Aminex Therapeutics, Inc.Photos of Professor Michelle Haber AM Executive Director of Children's Cancer Institute Australia Credit: Children’s Cancer Institute AustraliaThe MYCN oncogene has lon

Potential way to treat and prevent cancer in children with neuroblastoma

by Aminex Therapeutics, Inc.Photos of Professor Michelle Haber AM Executive Director of Children's Cancer Institute Australia Credit: Children’s Cancer Institute AustraliaThe MYCN oncogene has lon
Researchers use EHRs to identify cancer symptom clusters

Researchers use EHRs to identify cancer symptom clusters

by Regenstrief InstituteKun Huang, Ph.D. of Regenstrief Institute and Indiana University School of Medicine and Xiao Luo, Ph.D.of IUPUI conducted a study using electronic health records to identi

Researchers use EHRs to identify cancer symptom clusters

by Regenstrief InstituteKun Huang, Ph.D. of Regenstrief Institute and Indiana University School of Medicine and Xiao Luo, Ph.D.of IUPUI conducted a study using electronic health records to identi
Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis
New cancer strategies promising, says researcher

New cancer strategies promising, says researcher

by Martin Herrema,University of KentCancer cell during cell division. Credit: National Institutes of HealthDr. Tim Fenton, an expert in cancer research at the University, says the announcement o

New cancer strategies promising, says researcher

by Martin Herrema,University of KentCancer cell during cell division. Credit: National Institutes of HealthDr. Tim Fenton, an expert in cancer research at the University, says the announcement o
Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma

Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma

by Johns Hopkins University School of MedicineA microscopic image of intramedullary osteosarcoma. Johns Hopkins researchers have trained a machine learning model use such images to calculate perc

Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma

by Johns Hopkins University School of MedicineA microscopic image of intramedullary osteosarcoma. Johns Hopkins researchers have trained a machine learning model use such images to calculate perc
New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe
Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will
Researchers develop tool to measure patient health and well-being after radionuclide therapy

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that
A new tool to screen drugs that target loss of tumor suppressor genes

A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's

A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's
French Polynesia nuke tests slightly increased cancer risk: Study

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif
Researchers move closer to 'magic' cancer treatment

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th